Media Mentions
|
7/15/14 Harvard GazetteViewing how neurons work (featuring Adam Cohen, PhD) 7/7/14
|
|
Enhancing corneal regrowth
Natasha Frank, MD, Markus Frank, MD, and collaborators purify best stem cell type to regenerate damaged corneas.
A team of MEEI, Children's, BWH, and VA Healthcare Systems investigators used purified human limbal stem cells to improve long-term vision in mice with corneal blindness. The team is now pursuing FDA-approval for the technique before moving on to clinical trials. The results were published in Nature. Read the rest of the story.
|
Mesenchymal 'buddy system'
Juan Melero-Martin, PhD, and team find improved mesenchymal survival when co-transplanted with ECFCs.
Boston Children's Hospital scientists are exploring why the regenerative capabilities of mesenchymal stem cells have not translated in clinical trials. One problem is that the cells don't stick around long enough to help patients. Co-transplanting ECFCs that mesenchymal stem cells naturally hang out with in the body seems to help. Their work was published in PNAS. Read the full story. |
Visual: Hematopoeitic Niche
David Scadden, MD, and postdocs generate visual of ongoing work in the hematopoietic stem cell niche
|
|
|
Literature Highlights
- Sabbisetti, et. al, Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes, JASN. (June 5, 2014)
- Asimaki, et. al., Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy, Sci. Transl. Med. (June 11, 2014)
- Sinkevicius, et. al, Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis, PNAS. (July 15, 2014)
|
|
|
|
|